Cardiovascular Health Improvement Project

Heart Failure Clinical Trial

— CHIP  

Official title:

Cardiovascular Health Improvement Project

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02306200
• Other study ID #: HUM00052866
• Status: Recruiting
• Start date: August 2013
• Est. completion date: August 2053

Study information

• Verified date: May 2023
• Source: University of Michigan
• Contact: Lauren Humphrey-Stark, BS
• Phone: 7342324779
• Email: ljeany[@]med.umich.edu
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The goal of this project is to establish a biobank of clinical information, DNA, plasma, and aortic tissue samples from patients with cardiovascular disease as well as healthy controls.

Description:

The goal of this project is to establish a biobank of clinical information, DNA, plasma, and aortic tissue samples from patients with cardiovascular disease as well as healthy controls. The aims of the study are to collect biological specimens (blood, plasma, serum, aortic tissue) and family history; establish a biobank, establish a comprehensive database with information from consented patients, and provide researchers with high quality well annotated DNA samples with demographic and clinical information.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 9999
• Est. completion date: August 2053
• Est. primary completion date: August 2053
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Any patient over the age of 18 who is able/willing to give informed consent

• Patients <18 years of age with parental consent and assent (if assent is applicable for their age)

• Diagnosis of:

• aortic pathology potentially due to a known or suspected inherited condition

• Idiopathic aortic aneurysm

• Interesting of novel vascular pathology in the aorta or main branches

• Family history of aortic or vascular disease

• Other cardiovascular disease

• Healthy controls with no apparent cardiovascular disease

Exclusion Criteria:

• Not willing or able to sign the consent

Related Conditions & MeSH terms

• Aneurysm
• Aortic Aneurysm
• Aortic Dissection
• Bicuspid Aortic Valve (BAV)
• Bicuspid Aortic Valve Disease
• Cardiovascular Diseases
• Heart Failure

Locations

Country	Name	City	State
United States	University of Michigan	Ann Arbor	Michigan

Sponsors (1)

Lead Sponsor	Collaborator
University of Michigan

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Establishing a biobank of patients with Aortic Disease	Establish a biobank of blood, serum, plasma, tissue, and clinical data of patients with any form of aortic disease	40 years